Skip to main content
. 2023 Jun 15;64(4):395–403. doi: 10.4111/icu.20230009

Table 3. Comparison of assessment variables of the patients.

Variable Pre-treatment 6th week p-value
Severity of incontinence (Pad test) 55 (115–25) 7 (14–1) <0.001
Frequency 12 (15–10) 7 (8–6) <0.001
Nocturia 3 (4–2) 1 (2–1) <0.001
Incontinence episodes 4 (7–3) 1 (2–1) <0.001
Number of pads 3 (4–2) 1 (1–0) <0.001
Symptom severity (OAB-V8) 28 (33–22) 6 (8–4) <0.001
Quality of life (IIQ7) 11 (16–5) 2 (3–1) <0.001

Values are presented as median (ınterquartile range); IQR=3rd quartile–1st quartile.

OAB-V8, Overactive Bladder Questionnaire; IIQ-7, Incontinence Impact Questionnaire.

p-value by Wilcoxon signed-rank test.